Satoshi Yawata1,2, Kenichi Noda3, Ai Shimomura3, Akio Kuroda4. 1. Medical Related Devices Department, DKK-TOA Corporation, Sayama, Saitama, 350-1388, Japan. s-yawata@toadkk.co.jp. 2. Unit of Molecular Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8530, Japan. s-yawata@toadkk.co.jp. 3. Research and Development Planning Department, DKK-TOA Corporation, Sayama, Saitama, 350-1388, Japan. 4. Unit of Molecular Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8530, Japan. akuroda@hiroshima-u.ac.jp.
Abstract
OBJECTIVES: Firefly luciferase, one of the most extensively studied enzymes, has numerous applications. However, luciferase activity is inhibited by sodium chloride. This study was aimed at obtaining mutant luciferase enzymes resistant to the sodium chloride inhibition. RESULTS: We first obtained two mutant luciferase enzymes whose inhibition were alleviated and determined the mutations to be Val288Ile and Glu488Val. Under medical dialysis condition (140 mM sodium chloride), the wild type was inhibited to 44% of its original activity level. In contrast, the single mutants, Val288Ile and Glu488Val, retained 67% and 79% of their original activity, respectively. Next, we introduced Val288Ile and Glu488Val mutations into wild-type luciferase to create a double mutant using site-directed mutagenesis. Notably, the double mutant retained its activity more than 95% of that in the absence of sodium chloride. CONCLUSIONS: The mutant luciferase, named luciferase CR, was found to retain its activity in various concentrations of sodium chloride. The luciferase CR may be extensively useful in any bioassay which includes firefly luciferase and is employed in the presence of sodium chloride.
OBJECTIVES: Firefly luciferase, one of the most extensively studied enzymes, has numerous applications. However, luciferase activity is inhibited by sodium chloride. This study was aimed at obtaining mutant luciferase enzymes resistant to the sodium chloride inhibition. RESULTS: We first obtained two mutant luciferase enzymes whose inhibition were alleviated and determined the mutations to be Val288Ile and Glu488Val. Under medical dialysis condition (140 mM sodium chloride), the wild type was inhibited to 44% of its original activity level. In contrast, the single mutants, Val288Ile and Glu488Val, retained 67% and 79% of their original activity, respectively. Next, we introduced Val288Ile and Glu488Val mutations into wild-type luciferase to create a double mutant using site-directed mutagenesis. Notably, the double mutant retained its activity more than 95% of that in the absence of sodium chloride. CONCLUSIONS: The mutant luciferase, named luciferase CR, was found to retain its activity in various concentrations of sodium chloride. The luciferase CR may be extensively useful in any bioassay which includes firefly luciferase and is employed in the presence of sodium chloride.
Entities:
Keywords:
Alleviation; Luciferase; Mutation; Salt inhibition
Authors: James J Cali; Dongping Ma; Mary Sobol; Daniel J Simpson; Susan Frackman; Troy D Good; William J Daily; David Liu Journal: Expert Opin Drug Metab Toxicol Date: 2006-08 Impact factor: 4.481
Authors: Bruce R Branchini; Tara L Southworth; Neelum F Khattak; Elisa Michelini; Aldo Roda Journal: Anal Biochem Date: 2005-10-01 Impact factor: 3.365
Authors: Bruce R Branchini; Tara L Southworth; Martha H Murtiashaw; Henrik Boije; Sarah E Fleet Journal: Biochemistry Date: 2003-09-09 Impact factor: 3.162